Formoterol (Oxis Turbohaler) - Chronic Obstructive Pulmonary Disease (COPD)
You are here : Home > Formulary Search > Formoterol (Oxis Turbohaler) - Chronic Obstructive Pulmonary Disease (COPD)
Status 1
- Inhaler (dry powder)
Documentation
PAD Profile
Oxis Turbohaler
LABA monotherapy no longer recommended for asthma or COPD.
Not for initiation in new patients.
Other Indications
Below are listed other indications that Formoterol (Oxis Turbohaler) is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).
- Aclidinium bromide (Eklira Genuair)
- Aclidinium with formoterol (Duaklir Genuair)
- Beclometasone with formoterol (Fostair NEXThaler 100/6)
- Beclometasone with formoterol (Fostair)
- Beclometasone with formoterol (Proxor 100/6)
- Beclometasone with formoterol and glycopyrronium (Trimbow 87/5/9)
- Beclometasone with formoterol and glycopyrronium (Trimbow NEXThaler)
- Budesonide nebules
- Budesonide with formoterol (DuoResp Spiromax)
- Budesonide with formoterol (Fobumix Easyhaler)
- Budesonide with formoterol (Symbicort 200/6)
- Budesonide with formoterol (Symbicort Turbohaler 400/12)
- Dupilumab
- Fluticasone with salmeterol (Fusacomb Easyhaler)
- Fluticasone with salmeterol (Seretide Accuhaler)
- Fluticasone with umeclidinium and vilanterol (Trelegy Ellipta)
- Fluticasone with vilanterol (Relvar Ellipta)
- Formoterol (Easyhaler Formoterol)
- Glycopyrronium (Seebri Breezhaler)
- Glycopyrronium with formoterol (Bevespi Aerosphere)
- Glycopyrronium with indacaterol (Ultibro Breezhaler)
- Indacaterol (Onbrez Breezhaler)
- Ipratropium (Atrovent)
- Ipratropium (nebules)
- Ipratropium with salbutamol (nebules)
- Olodaterol (Striverdi Respimat)
- Roflumilast
- Salbutamol (Easyhaler Salbutamol)
- Salbutamol (nebules)
- Salbutamol (Salamol Easi-Breathe)
- Salbutamol (Salamol)
- Salbutamol (Salbulin Novolizer)
- Salbutamol (Ventolin Accuhaler)
- Salbutamol (Ventolin Evohaler)
- Salmeterol (Serevent Evohaler / Serevent Accuhaler)
- Spacer / holding chamber device
- Spacer / holding chamber device with mask
- Terbutaline (Bricanyl Turbohaler)
- Terbutaline (nebules / injection)
- Tiotropium (Braltus Zonda)
- Tiotropium (Spiriva HandiHaler)
- Tiotropium bromide (Spiriva Respimat)
- Tiotropium with olodaterol (Spiolto Respimat)
- Umeclidinium (Incruse Ellipta)
- Umeclidinium with vilanterol (Anoro Ellipta)
Committee Recommendations (1)
Single device LABA is not recommended in Asthma or COPD.
Combined LAMA/LABA is the bronchodilator treatment of choice for patients with COPD who are breathless or having exacerbations following treatment with SABA.
Existing LABA patients, whose symptoms are under control, can continue with their current treatment until both they and their NHS healthcare professional agree it is appropriate to change.
Inhaler devices should be prescribed by BRAND.
See COPD guidelines for more information
See COPD local guidelines for more information